Ioxaglate

also known as Acide ioxaglique · Acido ioxaglico · Ioxaglate meglumine component of hexabrix · IOXAGLATE SODIUM · Ioxaglate sodium component of hexabrix · MP-302 · Sodium ioxaglate

Diagnostic / imaging agent

Investigated by: Guerbet · NYU Langone Health

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

Milestone	Jurisdiction	Brand	Indication	Date	Sentence it was read from
Approved	US (FDA)	HEXABRIX	—	1985-07-26	fda.gov ↗

Trials 1 · a red edge is where a trial was stopped

today

US approved 1985

NCT01848899 · Ph 4

1985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT01848899	Feb → Nov 2013	coronary artery disorder	NYU Langone Health	Completed	No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Ioxaglate	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01848899 ↗
Known as	Acide ioxaglique	ChEMBL registry synonym — accepted as the source's own label CHEMBL1201291 ↗
Known as	Acido ioxaglico	ChEMBL registry synonym — accepted as the source's own label CHEMBL1201291 ↗
Known as	Ioxaglate meglumine component of hexabrix	ChEMBL registry synonym — accepted as the source's own label CHEMBL1201291 ↗
Known as	IOXAGLATE SODIUM	ChEMBL registry synonym — accepted as the source's own label CHEMBL1201291 ↗
Known as	Ioxaglate sodium component of hexabrix	ChEMBL registry synonym — accepted as the source's own label CHEMBL1201291 ↗
Known as	MP-302	ChEMBL registry synonym — accepted as the source's own label CHEMBL1201291 ↗
Known as	Sodium ioxaglate	ChEMBL registry synonym — accepted as the source's own label CHEMBL1201291 ↗
Modality	Diagnostic / imaging agent	“contrast media used during coronary angiography” NCT01848899 ↗